Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations

Oba-Shinjo, Sueli M.; Silva, Roseli da; Andrade, Fernanda G.; Palmer, Rachel E.; Pomponio, Robert J.; Ciociola, Kristina M.; Carvalho, Mary S.; Gutierrez, Paulo S.; Porta, Gilda; Marrone, Carlo D.; Munoz, Verônica; Grzesiuk, Anderson K.; Llerena Junior, Juan Clinton; Berditchevsky, Célia R.; Sobreira, Claudia; Horovitz, Dafne Dain Gandelman; Hatem, Thamine P.; Frota, Elizabeth R. C.; Pecchini, Rogerio; Kouyoumdjian, João Aris; Werneck, Lineu; Amado, Veronica M.; Camelo Jr., José S.; Mattaliano, Robert J.; Marie, Suely K. N..
Artículo en Inglés | ARCA | ID: arc-8531

Documentos relacionados

  1. Current avenues of gene therapy in Pompe disease.
  2. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
  3. Infantile-onset Pompe disease in seven Mexican children.
  4. Late Onset Pompe's Disease: Clinical, Pathological & Molecular Analysis of Two Adolescent Patients.
  5. Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening.
  6. [Analysis of lysosomal enzyme activity and genetic variants in a child with late-onset Pompe disease].
  7. [Diagnosis and Management of Late-Onset Pompe Disease].
  8. Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening.
  9. Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know.
  10. Long-term outcomes of very early treated infantile-onset Pompe disease with short-term steroid premedication: experiences from a nationwide newborn screening programme.